Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125495911 | 12549591 | 1 | I | 20160614 | 20160712 | 20160712 | PER | US-PFIZER INC-2016303667 | PFIZER | 70.00 | YR | M | Y | 117.91000 | KG | 20160712 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125495911 | 12549591 | 1 | PS | TIKOSYN | DOFETILIDE | 1 | Oral | 250 UG, 2X/DAY | U | 20931 | 250 | UG | CAPSULE, HARD | BID | |||||
| 125495911 | 12549591 | 2 | SS | TIKOSYN | DOFETILIDE | 1 | Oral | 250 UG, DAILY (EVERY DAY) | U | 20931 | 250 | UG | CAPSULE, HARD | ||||||
| 125495911 | 12549591 | 3 | C | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, 1X/DAY (WITH DINNER) | 0 | 20 | MG | TABLET | QD | ||||||
| 125495911 | 12549591 | 4 | C | ALFUZOSIN HCL | ALFUZOSIN HYDROCHLORIDE | 1 | Oral | 10 MG, DAILY (EVERY DAY) | 0 | 10 | MG | PROLONGED-RELEASE TABLET | |||||||
| 125495911 | 12549591 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, DAILY | 0 | 81 | MG | TABLET | |||||||
| 125495911 | 12549591 | 6 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
| 125495911 | 12549591 | 7 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 UG, AS NEEDED (50MCG/ACT) | 0 | 50 | UG | NASAL SPRAY | |||||||
| 125495911 | 12549591 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 125495911 | 12549591 | 9 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 12.5 MG, 2X/DAY | 0 | 12.5 | MG | TABLET | BID | ||||||
| 125495911 | 12549591 | 10 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 125495911 | 12549591 | 11 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 62.5 UG, 1X/DAY | 0 | 62.5 | UG | TABLET | QD | ||||||
| 125495911 | 12549591 | 12 | C | FISH OIL | FISH OIL | 1 | Oral | 1000 MG, 2X/DAY | 0 | 1000 | MG | CAPSULE | BID | ||||||
| 125495911 | 12549591 | 13 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 400 MG, DAILY (EVERY DAY) | 0 | 400 | MG | CAPSULE |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125495911 | 12549591 | Influenza | |
| 125495911 | 12549591 | Insomnia | |
| 125495911 | 12549591 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |